Owner Onyx Pharmaceuticals, Inc.

Inventors Shen, Yuqiao Jerry; Shen, Annie; Sevilla, Elizabeth; Aspelund, Amy; Perez, Aleida

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009202033

Parent 2004260044

Filing date 22 May 2009

Wipo publication date 11 June 2009

C12N 15/00 (2006.01) Mutation or genetic engineering

A01N 63/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors